Sanger Institute Sequences 240 Pneumococcal Isolates to Track Evolution of Drug Resistance

The study highlights the potential of next-generation sequencing to identify variants that allow pathogenic bacteria to evade drugs, and could enable the development of new therapies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.